CD8A and myeloid sarcoma: Studies have also shown impaired EBV-specific CD8 T cell responses in MS patients (21, –, 23) and a decreased frequency or functionality of EBV-specific CD8 T cells with increasing disease duration (18, 22, 23), suggesting T-cell exhaustion due to a persistently active infection.